NCT04679597View on ClinicalTrials.gov

Total Neoadjuvant Therapy Versus Standard Therapy of Locally Advanced Rectal Cancer With High Risk Factors for Failure

CompletedOBSERVATIONAL
Enrollment

161

Participants

Timeline

Start Date

January 1, 2016

Primary Completion Date

December 31, 2019

Study Completion Date

December 31, 2019

Conditions
Rectal Cancer
Interventions
DRUG

Capecitabine

comparison of two treatments

All Listed Sponsors
lead

Institute of Oncology Ljubljana

OTHER

NCT04679597 - Total Neoadjuvant Therapy Versus Standard Therapy of Locally Advanced Rectal Cancer With High Risk Factors for Failure | Biotech Hunter | Biotech Hunter